Introduction: The REGAL (RSV [respiratory syncytial virus] Evidence-a Geographical Archive of the Literature) series provides a comprehensive review of the published evidence in the field of RSV in Western countries over the last 20 years. This first of seven publications covers the epidemiology and burden of RSV infection.
INTRODUCTION
Respiratory syncytial virus (RSV) is the most common cause of infection of the upper and lower respiratory tract in infants and young children worldwide and a major public health burden [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Globally, there are an estimated 33 million annual cases of RSV-associated lower respiratory tract infection in children under the age of 5 years, with at least 3.4 million episodes necessitating admission to hospital [1] .
Although the risk of hospital admission is higher in known risk groups, such as those born prematurely, in particular, those with chronic lung disease (CLD)/bronchopulmonary dysplasia (BPD), and those with congenital heart disease (CHD) [11] [12] [13] [14] [15] , the majority of severe cases of RSV infection occur among previously healthy term infants [14, 16] . Severe RSV infection remains a significant unmet medical need, and reducing the health burden of RSV has become a priority of the World Health Organization's (WHO) BRaVe (Battle against Respiratory Viruses) initiative [17, 18] . Part of the research agenda of this initiative is to define the burden of respiratory viral infections [18] .
Over the last 20 years, there has been a considerable body of research published on RSV that has improved our understanding of the epidemiology in different risk groups, the acute and long-term burden to children and to healthcare systems, the underlying infection process and genetics, as well as preventive and management strategies. An understanding of the incidence and complications of RSV disease is essential for planning strategies to control RSV infection and to optimize the use of RSV prophylaxis and future RSV vaccines [19] [20] [21] .
To provide a comprehensive understanding on severe RSV disease in infants and children in Western societies, an expert panel, comprising
Neonatologists, Pediatricians, Pediatric Infectious Disease Specialists, Pediatric Cardiologists and Pediatric Pulmonologists from the United States, Canada and Europe, undertook an evidence-based search of the literature which has accumulated over the past two decades. The primary objective of REGAL (RSV Evidence-a Geographical Archive of the Literature) was to carry out a series of systematic literature reviews and, then, to assess, quantify, summarize and grade the evidence base. By undertaking this review, the current state of the art in our understanding of RSV was defined as well as, importantly, gaps in our knowledge and future areas of research. This paper represents the first of a series of seven publications encompassing different areas of the systematic review and covers in detail the overall methodology that was followed for each of the reviews, and summarizes the first topic:
the epidemiology and burden of severe RSV infection requiring hospitalization among infants and children in Western societies.
METHODS

Objectives
The primary objective of REGAL was to address seven specific research questions ( Table 1 ). The systematic literature reviews undertaken to answer each of these research questions all used the same broad methodology, which is described in detail below.
Search Strategy and Selection Criteria
Following a study protocol with pre-defined search terms, we conducted a systematic and comprehensive search of the medical literature electronically indexed in MEDLINE (PubMed), Embase and The Cochrane Library. Search strategies were devised for each systematic review and combined free-text search terms with medical subject headings (MeSH). An important part of the protocol was the countries to be included. The overall burden of RSV has been studied in many industrialized countries, and therefore, to ensure a manageable volume of publications, only studies conducted in Western countries were included, which we defined as the United States, Canada, and Europe (including Turkey and the Russian quality assessment for each citation was carried out using the five-point (1 = low quality; 5 = high quality) Jadad Scale [24] . For each study, we also conducted a risk of bias assessment using the RTI Item Bank (score of 1 = very high risk of bias; score of 12 = very low risk of bias) for observational studies [25] and the Cochrane Collaboration's tool for assessing risk of bias for randomized clinical trials [26] .
METHODS USED FOR CURRENT STUDY: OVERALL EPIDEMIOLOGY AND BURDEN OF RSV
The target population for the first systematic literature review in our series was previously healthy term children or studies with mixed populations of term and preterm (\37 wGA) children and those with comorbidities. We excluded studies that focused exclusively on particular subgroups, such as preterm infants (\37 wGA), those with CLD/BPD or CHD, or other medical conditions (e.g. Down syndrome), since this systematic literature review considers the overall epidemiology and burden of RSV in infants and children.
However, studies were included if a proportion of the study population had comorbidities.
In this first systematic literature review, we sought to answer the following question: 1. What is the overall epidemiology and disease burden of severe RSV infection in 
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RESULTS AND DISCUSSION
Articles Selected
A total of 98 publications were included in the final review: 90 identified from the database searches and a further 8 from reference lists/ other sources ( Fig. 1 ). Data extraction tables for all 98 studies, including evidence grades and risk of bias assessments, can be found in the online supplement (Supplementary Material 2-Data Extraction Table) .
Incidence of RSV Hospitalization
RSV has been associated with 12-63% of all acute respiratory infections (ARIs) [12, 16, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and 19-81% of viral ARIs causing hospitalization in infants and children [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] (Table 2 ). Importantly, while high-risk groups are particularly vulnerable to severe infection and are often the focus of study, the majority (typically [70%) of children Carbonell-Estrany were not required to resolve any disagreements during the review process Table 2 ). The reported rates of RSVH, however, vary considerably between studies and across seasons within the same study.
Incidence of RSV in Emergency
Departments and Outpatient Settings
There are very limited data available on the incidence and burden of RSV infection managed on an outpatient basis or in the emergency department [14, 60] . Available studies suggest that the outpatient burden of RSV on healthcare resources has not been fully recognized by healthcare providers [14] . For example, a US study reported that only 3% of patients with bacterial co-infection and 5 with viral co-infection (P = 0.69). The most common co-infections were RV and RSV-B (10 cases) and RSV-A and RSV-B (5 cases) [80] . Findings from an earlier Canadian study of 742 children suspected to have a respiratory illness (33% with a comorbidity) support equivalent disease severity between single virus infection and virus co-infection [82] . In multivariable analysis, virus co-infection did not affect admission to hospital after adjustment for age and the presence of underlying conditions [82] .
Morbidity and Mortality Associated
with Severe RSV Infection
Morbidity
Severe RSV infection in infants and children is associated with substantial morbidity and constitutes a considerable burden on healthcare systems [83] . Kristensen et al. [83] showed that, compared with infants without predisposing conditions (aged \6 months), infants with predisposing conditions were hospitalized longer (median 5 vs. 9 days; P\0.001) and were treated longer with continuous positive airway pressure (CPAP) (median 4 vs. 7 days; P\0.001) and supplemental oxygen (median 3 vs. 5 days; P = 0.05). In term infants without predisposing conditions, age was a predictor of disease severity. Age correlated inversely with duration of oxygen therapy (P\0.02), and infants treated with oxygen or CPAP were significantly younger than infants who did not receive respiratory support (oxygen: median age, 52 vs. 91 days; P\0.001; CPAP: median age, 51 vs. 90 days; P = 0.001) [83] . Müller-Pebody et al. [34] observed that hospital LOS was significantly higher (P\0.001) in high-risk children aged \1 year and in those aged 1-4 years. While Gijtenbeek et al. [88] observed higher hospitalization rates for confirmed RSV infection among preterm infants (32-36 wGA) than full-term infants, disease severity, length of hospitalization and the use of mechanical ventilation and oxygen were similar between gestational groups (Table 3) .
Studies have shown that RSV ARI is associated with more severe disease than non-RSV ARI, resulting in a significant impact on healthcare resource utilization [12, 44, 57] . On average, infants spend 2-11 days in hospital for RSV ARIs, with around 2-12% being admitted to ICU ( [6] reported that infants younger than 6 months had the longest duration of hospital stay. Perhaps unsurprisingly, different geographic regions have varying criteria for admission to hospital and subsequent management [89, 90] , which can make comparisons of disease severity difficult. P\0.001) [93] .
Case-Fatality Rates
The Global Burden of Disease study estimated that RSV accounted for 1.6% of deaths worldwide in 2010 [95] . Presence of older sibling [2, 108] Birth in proximity to RSV season [16, 109, 110] Low birth weight [108, 110] Birth order [33, 109] Male sex [108] Young age (\6 months) [14, 16, 27, 100] Exposure to smoking [86, 101, 108] Maternal age [110] Suburban residence [110] Other risk factors associated with RSV hospitalization Vitamin D deficiency [111] Family history of atopy/atopic diagnosis [101, 112, 113] Climatic factors and air pollution [114] [115] [116] High altitude above 2500 m [104] Socioeconomic status/parental education [117] Delivery by cesarean section [105] Level of evidence a
Key statements/findings
In western countries, RSV has been associated with 12-63% of all ARIs and 19-81% of viral ARIs causing hospitalization in children aged 1 year to 0.18% in children aged 4 years [4] .
In several studies, the case-fatality rate was higher among high-risk children, including those with BPD/CLD, CHD and immunodeficiency [4, 7, 11, 34] .
Risk Factors for RSV Hospitalization
Several important independent risk factors for RSV hospitalization have been identified, including male gender, birth in proximity to RSV season, history of prematurity and tobacco smoke exposure (Table 4 ). Age, in particular, has been found to be a significant predictor in the severity of infection and RSV hospitalization, with the youngest age groups (\6 months) more frequently hospitalized for a RSV infection [14, 16, 27, 100, 101] . In contrast, some risk factors, such as breastfeeding, have been found to be protective [33, 102] . While the predominance of severe RSV bronchiolitis in boys compared to girls is well known, its mechanism is not yet understood [103] . A study found that the interleukin-9 genetic polymorphism (rs2069885) has an opposite effect on the risk of severe RSV bronchiolitis in boys and girls [103] . Some lesser known risk factors reported in the literature include high altitude above 2500 m [104] , maternal atopy [101] and delivery by cesarean section [105] .
Black and aboriginal race has also been shown in some studies to be a risk factor for severe disease [ shell vial culture, and viral culture, which are generally less sensitive than current PCR (polymerase chain reaction)-based assays. As described above, some studies, particularly the older ones, tended to describe the epidemiology and burden of bronchiolitis or ARIs without a totally accurate measure of how much of that burden or any additional burden related to RSV. We consider that there is a really important economical impact of RSV infection on emergency departments and outpatients, on co-infections, and on RSV-specific mortality rates. Unfortunately, there are also limited economical data of outpatient RSV economical burden For this reason, this review may underestimate the true burden of RSV.
CONCLUSIONS
Despite the availability of current preventative measures, the findings of this review confirm that RSVH still represents a large burden of disease in Western countries since it is associated with significant morbidity. Further studies focused on the epidemiology and the incidences of RSV ARIs to determine the true burden of disease, particularly in the outpatient setting, are needed.
Well-coordinated surveillance programs within and across Western countries involving centers and hospitals with robust electronic medical records systems for patient identification and that test a high proportion of hospitalized children or visiting outpatients with respiratory illness for RSV, would be the ideal.
Also, the development of more effective preventive strategies in high-risk children, as well as in healthy populations, is essential to reduce the overall burden of RSV ARI, which will be the focus of a subsequent paper in the REGAL series. 
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